7

Arete Therapeutics Closes $16.7 Million in Final Tranche of Its Series A Financing (PR Newswire)

http://us.rd.yahoo.com –

Arete Therapeutics Inc., a privately-held biotechnology company developing first-in-class soluble epoxide hydrolase inhibitors, today announced that it has closed the final tranche of its Series A financing.

Read »
6 weeks 5 days ago – Made popular 6 weeks 5 days ago
Category: Venture Capital   Tags:

Similar stories

The X-Change Corporation Closes on Second $1.8 Million Tranche of $3.6 Million Financing (Business Wire) 24 weeks 6 days ago
OrthoScan, Inc. Closes $7.5 Million Series B Financing (Business Wire) 12 weeks 5 days ago
Intradigm Raises $18.5 Million in Series B Financing (PR Newswire) 13 weeks 4 days ago
IRX Therapeutics Completes $25 Million Series A Preferred Stock Offering (Business Wire) 30 weeks 6 days ago

Navigation

What we're reading:

cover of The Education of a Speculator
The Education of a Speculator

User login

Weekly Review

Stay informed on our latest news!

If you don't see your content here, learn more about importing to on this page.
Private Equity News and Advice